{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:07:41Z","timestamp":1782821261361,"version":"3.54.5"},"reference-count":36,"publisher":"Wiley","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Vascular Medicine"],"published-print":{"date-parts":[[2020,12,21]]},"abstract":"<jats:p>Introduction. Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications. Methods. This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group. Results. Patients (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>n<\/a:mi>\n                        <a:mo>=<\/a:mo>\n                        <a:mn>202<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>=<\/c:mo>\n                        <c:mn>0.016<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>) and serum albumin at admission (<jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>=<\/e:mo>\n                        <e:mn>0.001<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>) were statistically significant predictors of overall death. Age (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>=<\/g:mo>\n                        <g:mn>0.002<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula>), HTN (<jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>=<\/i:mo>\n                        <i:mn>0.002<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>), DM (<jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>=<\/k:mo>\n                        <k:mn>0.02<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula>), and the use of diuretics (<jats:inline-formula>\n                     <m:math xmlns:m=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <m:mi>P<\/m:mi>\n                        <m:mo>=<\/m:mo>\n                        <m:mn>0.001<\/m:mn>\n                     <\/m:math>\n                  <\/jats:inline-formula>) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; <jats:inline-formula>\n                     <o:math xmlns:o=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\">\n                        <o:mi>P<\/o:mi>\n                        <o:mo>=<\/o:mo>\n                        <o:mn>0.63<\/o:mn>\n                     <\/o:math>\n                  <\/jats:inline-formula>). Some inflammatory markers (NGAL <jats:inline-formula>\n                     <q:math xmlns:q=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M9\">\n                        <q:mi>P<\/q:mi>\n                        <q:mo>=<\/q:mo>\n                        <q:mn>0.06<\/q:mn>\n                     <\/q:math>\n                  <\/jats:inline-formula>, IL-19 <jats:inline-formula>\n                     <s:math xmlns:s=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M10\">\n                        <s:mi>P<\/s:mi>\n                        <s:mo>=<\/s:mo>\n                        <s:mn>0.08<\/s:mn>\n                     <\/s:math>\n                  <\/jats:inline-formula>) and serum albumin at admission <jats:inline-formula>\n                     <u:math xmlns:u=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M11\">\n                        <u:mi>P<\/u:mi>\n                        <u:mo>=<\/u:mo>\n                        <u:mn>0.07<\/u:mn>\n                     <\/u:math>\n                  <\/jats:inline-formula> had a trend toward a statistically significant impact on recatheterization. Death (<jats:inline-formula>\n                     <w:math xmlns:w=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M12\">\n                        <w:mi>P<\/w:mi>\n                        <w:mo>=<\/w:mo>\n                        <w:mn>0.66<\/w:mn>\n                     <\/w:math>\n                  <\/jats:inline-formula>) and need for recatheterization (<jats:inline-formula>\n                     <y:math xmlns:y=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M13\">\n                        <y:mi>P<\/y:mi>\n                        <y:mo>=<\/y:mo>\n                        <y:mn>0.63<\/y:mn>\n                     <\/y:math>\n                  <\/jats:inline-formula>) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (<jats:inline-formula>\n                     <ab:math xmlns:ab=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M14\">\n                        <ab:mi>P<\/ab:mi>\n                        <ab:mo>=<\/ab:mo>\n                        <ab:mn>0.004<\/ab:mn>\n                     <\/ab:math>\n                  <\/jats:inline-formula>). Conclusion. CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.<\/jats:p>","DOI":"10.1155\/2020\/8864056","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T01:35:23Z","timestamp":1608600923000},"page":"1-6","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country"],"prefix":"10.1155","volume":"2020","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7581-2025","authenticated-orcid":true,"given":"Ashraf O.","family":"Oweis","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameeha A.","family":"Alshelleh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen","family":"Saadeh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad I.","family":"Jarrah","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Ibdah","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-5099","authenticated-orcid":true,"given":"Karem H.","family":"Alzoubi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","article-title":"Contrast-induced acute kidney injury: review and practical update","volume":"13, article 1179546819878680","author":"R. Morcos","year":"2019","journal-title":"Clinical Medicine Insights Cardiology"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53040-5"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.04.055"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666191211112800"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1177\/0003319716676173"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0498-y"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-311975"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.12.029"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S171930"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.005715"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040847"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-2"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26928"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-016-0184-1"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2018.1551263"},{"key":"16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0003319714551979","article-title":"Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention","volume":"66","author":"S. N. Murat","year":"2014","journal-title":"Angiology"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S162764"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.3109\/0886022x.2014.991994"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-270"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2018.11.006"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.06.011"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.085290"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft082"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.03.005"},{"issue":"1508","key":"25","first-page":"29","article-title":"Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006-2016: ANZACS-QI 32 study","volume":"133","author":"T. K. M. Wang","year":"2020","journal-title":"The New Zealand Medical Journal"},{"key":"26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ccd.28404","article-title":"Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock","volume":"95","author":"A. F. Castro-Mejia","year":"2019","journal-title":"Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1073-8"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.02.028"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060810"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1159\/000503916"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1177\/2048872616640995"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4796-7"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S178020"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718801246"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.490"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.14800\/macrophage.562"}],"container-title":["International Journal of Vascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijvm\/2020\/8864056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijvm\/2020\/8864056.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijvm\/2020\/8864056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T01:35:28Z","timestamp":1608600928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ijvm\/2020\/8864056\/"}},"subtitle":[],"editor":[{"given":"Antonio","family":"Bozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":36,"alternative-id":["8864056","8864056"],"URL":"https:\/\/doi.org\/10.1155\/2020\/8864056","relation":{},"ISSN":["2090-2832","2090-2824"],"issn-type":[{"value":"2090-2832","type":"electronic"},{"value":"2090-2824","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,21]]}}}